financetom
Business
financetom
/
Business
/
Stellantis to pause production of Jeep's two top-selling US models, WSJ reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stellantis to pause production of Jeep's two top-selling US models, WSJ reports
Sep 6, 2024 12:46 PM

(Reuters) - Jeep's parent company Stellantis ( STLA ) is pressing pause on making two of its top-selling U.S. models, The Wall Street Journal reported on Wednesday.

Factories temporarily stopped producing the Jeep Wrangler and Grand Cherokee SUVs in the past week, the report added citing people familiar with the matter.

Stellantis ( STLA ) did not immediately respond to a Reuters request for comment.

Stellantis ( STLA ) confirmed "production adjustments" at two Detroit assembly plants that make the Grand Cherokee, and another factory in Toledo, Ohio, where the Wrangler is produced, in a statement to the Journal.

On Tuesday, the automaker named Bob Broderdorf who was its Ram brand operation's senior vice president and head of sales operations at Dodge, as the head of Jeep North America.

In July, U.S. auto safety regulator opened a recall query into 94,275 Jeep Wrangler 4xe hybrid SUVs manufactured between 2021 through 2024.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details
EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details
Aug 23, 2024
EHang Holdings Limited ( EH ) shares are trading higher after it reported second-quarter results. Revenue escalated 919.6% Y/Y to RMB102.0 million. In USD terms, revenue of $14.04 million beat the consensus of $12.58 million. Revenue benefitted from strong demand for the advanced EH216-S pilotless eVTOL vehicles. Gross profit surged 957.3% Y/Y to RMB63.7 million ($8.7 million), with a gross margin of 62.4%, up 2.2 percentage points Y/Y. Adjusted...
Advance Auto Parts to Sell Worldpac to Carlyle for $1.5 Billion in Cash
Advance Auto Parts to Sell Worldpac to Carlyle for $1.5 Billion in Cash
Aug 23, 2024
06:39 AM EDT, 08/22/2024 (MT Newswires) -- Advance Auto Parts ( AAP ) said Thursday it has agreed to sell Worldpac Inc., its automotive parts wholesale distribution business, to funds managed by Carlyle Group ( CG ) for $1.5 billion in cash. The company expects net proceeds of about $1.2 billion after taxes and transaction fees. The deal, slated to...
BRIEF-Proreit Announces Agreement To Acquire Industrial Building In Montréal For $32.6 Million
BRIEF-Proreit Announces Agreement To Acquire Industrial Building In Montréal For $32.6 Million
Aug 23, 2024
Aug 21 (Reuters) - PRO Real Estate Investment Trust : * PROREIT ANNOUNCES AGREEMENT TO ACQUIRE INDUSTRIAL BUILDING IN MONTRÉAL FOR $32.6 MILLION * PRO REAL ESTATE INVESTMENT TRUST: PURCHASE PRICE TO BE FINANCED THROUGH NEW $21.2 MILLION FIVE-YEAR FIRST MORTGAGE AT RATE OF 5.10% Source text for Eikon: Further company coverage: ...
Biogen, Eisai's Mild Dementia Treatment Gets Marketing Authorization From UK Regulatory Authority
Biogen, Eisai's Mild Dementia Treatment Gets Marketing Authorization From UK Regulatory Authority
Aug 23, 2024
06:31 AM EDT, 08/22/2024 (MT Newswires) -- Biogen (BIIB) and Japan's Eisai Co. ( ESALF ) said early Thursday that their humanized amyloid-beta monoclonal antibody, lecanemab, received marketing authorization from the UK's regulatory authority. The company said lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in certain types of adult patients....
Copyright 2023-2025 - www.financetom.com All Rights Reserved